International firm Pinsent Masons yesterday, August 13, revealed its financial results for 2025, with modest increases in revenue and profit per equity partner reported.
Firmwide revenue was £680 million ($923 million), an increase of 4.7%. Profit per equity partner was £797,000, an increase of 0.5% on 2024 (£793,000).
The figures were for the year ending April 30 2025.
Several of the major intellectual property wins for the firm during the reporting period were in the life sciences sector, where the firm announced new leadership during the reporting period.
In September last year, the firm named Judith Krens and Tom Nener as co-leads of the global IP practice and appointed partner Charlotte Weekes as its head of life sciences.
Life sciences focus
Among the firm’s life sciences wins included advising Accord Healthcare and Sandoz in successful proceedings at the England and Wales High Court and Court of Appeal, which resulted in the revocation of a patent covering Xarelto (rivaroxaban), a multimillion-pound anti-coagulant drug marketed by Bayer.
The life sciences team also represented Teva in its UK and Europe-wide litigation to revoke Bristol Myers Squibb’s compound patent and supplementary protection certificate concerning another anti-coagulant drug, Eliquis (apixaban).
Among other IP wins away from life sciences was being named the sole legal provider for Heineken UK, including for all the drinks company’s IP requirements.
On the transactions side, the firm advised retail investment company Modella Capital on the IP aspects of several restructuring and refinancing transactions involving high street brands, and acted for Aston University on a collaboration being led by the UK-based institution to develop sustainable bioenergy systems.
Earlier this year, the firm also made a triple partner hire to its IP team from Deloitte, as well as opening new offices in Shenzhen, China, and Riyadh, Saudi Arabia.
Senior partner Andrew Masraf said it had been another year “marked by geopolitical complexities and uncertain market conditions”, but that the firm’s continued growth signified a “validation of our strategy”.
He added: “Our appointment as Heineken’s sole legal provider in the UK reflects our ability to combine our legal and professional services experts in a way that addresses our clients’ strategic imperatives.”
Reporting season is in full swing, with firms such as Osborne Clarke, Simmons & Simmons, Fieldfisher, Lewis Silkin and Browne Jacobson having posted their results.
